Overview
Haifang Liu practices practicing medicine in Haikou, China.
Their clinical expertise encompasses Alpha Thalassemia, Thalassemia, Hemoglobinopathy, and Hemolytic Anemia.
They are actively involved in clinical research, co-authoring 14 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Haifang Liu
Is Haifang Liu a top-rated expert for Alpha Thalassemia?
MediFind is an objective health platform that identifies experts based on real-world data. Haifang Liu is classified as an Experienced expert for Alpha Thalassemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Haifang Liu participate in research or clinical trials?
Yes. Haifang Liu has published 14 articles and abstracts on conditions like Alpha Thalassemia. You can view a list of Haifang Liu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Alpha ThalassemiaLiu isExperienced. Learn about Alpha Thalassemia.
- Congenital Hemolytic Anemia
- HemoglobinopathyLiu isExperienced. Learn about Hemoglobinopathy.
- Hemolytic AnemiaLiu isExperienced. Learn about Hemolytic Anemia.
- ThalassemiaLiu isExperienced. Learn about Thalassemia.